Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death.

被引：0
|
作者：
Sanford, Nina Niu
Chen, Ming-Hui
Loffredo, Marian J.
Renshaw, Andrew A.
Kantoff, Philip W.
D'Amico, Anthony Victor
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Univ Connecticut, Dept Stat, Storrs, CT USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Baptist Hosp Miami, Miami, FL USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5070
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy
    D'Amico, Anthony V.
    Renshaw, Andrew A.
    Loffredo, Brittany
    Chen, Ming-Hui
    CANCER, 2007, 110 (08) : 1723 - 1728
  • [22] Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial
    Giacalone, Nicholas J.
    Wu, Jing
    Chen, Ming-Hui
    Renshaw, Andrew
    Loffredo, Marian
    Kantoff, Philip W.
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3781 - +
  • [23] Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy
    O'Farrell, Sean
    Sandstrom, Karin
    Garmo, Hans
    Stattin, Par
    Holmberg, Lars
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    BJU INTERNATIONAL, 2016, 118 (03) : 391 - 398
  • [24] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    JOURNAL OF UROLOGY, 2006, 175 (04): : 41 - 41
  • [25] Radiation and androgen deprivation therapy with or without docetaxel in the management of non-metastatic unfavorable-risk prostate cancer: A prospective randomized trial.
    D'Amico, Anthony Victor
    Xie, Wanling
    McMahon, Elizabeth
    Loffredo, Marian
    Medeiros, Shana
    Joseph, David John
    Denham, James William
    Lamb, David S.
    Kumar, Parvesh
    Bubley, Glenn
    Sullivan, Molly A.
    Hellwig, Richard
    Vera, Juan Carlos
    Freter, Rolf
    Baker, W. Jeffrey
    Wong, Jeffrey Y. C.
    Renshaw, Andrew A.
    Kantoff, Philip W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy
    Raldow, Ann C.
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    BRACHYTHERAPY, 2015, 14 (06) : 781 - 787
  • [27] Reply to duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy
    D'Amico, Anthony V.
    Chen, Ming-Hui
    CANCER, 2008, 112 (10) : 2323 - 2323
  • [28] Cancer-specific survival following radical prostatectomy or radiation therapy and short course hormonal therapy in men with localized, unfavorable-risk prostate cancer.
    Tsai, H. K.
    Chen, M.
    McLeod, D. G.
    Carroll, P. R.
    Richie, J. P.
    D'Amico, A. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 234S - 234S
  • [29] Optimal Duration of Androgen Deprivation in Combination with Radiation Therapy for Japanese Men with High-Risk Prostate Cancer
    Takaha, Natsuki
    Okihara, Koji
    Kamoi, Kazumi
    Kimura, Yasunori
    Yamada, Takeshi
    Kawauchi, Akihiro
    Kobayashi, Kana
    Yamazaki, Hideya
    Nishimura, Tsunehiko
    Miki, Tsuneharu
    UROLOGIA INTERNATIONALIS, 2011, 87 (01) : 28 - 34
  • [30] Low testosterone at first PSA failure and assessment of the risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.
    Atkins, Katelyn Mae
    Chen, Ming-Hui
    Wu, Jing
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    Small, Eric Jay
    D'Amico, Anthony Victor
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
12345